{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:54:44Z","timestamp":1781607284522,"version":"3.54.5"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alzheimer Stiftung G\u00f6ttingen"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["335\/454-1FUGG"],"award-info":[{"award-number":["335\/454-1FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, there has been growing evidence that cannabinoids have promising medicinal and pharmacological effects. However, the growing interest in medical cannabis highlights the need to better understand brain alterations linking phytocannabinoids or synthetic cannabinoids to clinical and behavioral phenotypes. Therefore, the aim of this study was to investigate the effects of long-term WIN 55,212-2 treatment\u2014with and without prolonged abstinence\u2014on cerebral metabolism and memory function in healthy wildtype mice. Adult C57BI\/6J mice were divided into two treatment groups to study the acute effects of WIN 55,212-2 treatment as well the effects of WIN 55,212-2 treatment after an extended washout phase. We could demonstrate that 3\u00a0mg\/kg WIN 55,212-2 treatment in early adulthood leads to a hypometabolism in several brain regions including the hippocampus, cerebellum, amygdala and midbrain, even after prolonged abstinence. Furthermore, prolonged acute WIN 55,212-2 treatment in 6-months-old mice reduced the glucose metabolism in the hippocampus and midbrain. In addition, Win 55,212-2 treatment during adulthood lead to spatial memory and recognition memory deficits without affecting anxiety behavior. Overall we could demonstrate that treatment with the synthetic CB1\/CB2 receptor aganist Win 55,212-2 during adulthood causes persistent memory deficits, especially when mice were treated in early adulthood. Our findings highlight the risks of prolonged WIN 55,212-2 use and provide new insights into the mechanisms underlying the effects of chronic cannabinoid exposure on the brain and behavior.<\/jats:p>","DOI":"10.1007\/s00702-023-02607-8","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:02:45Z","timestamp":1677589365000},"page":"1013-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice"],"prefix":"10.1007","volume":"130","author":[{"given":"Caroline","family":"Bouter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Wilhelm","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Weig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schmitz-Peiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahriban","family":"Rozyyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Beindorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"2607_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1936","author":"B Abd-Nikfarjam","year":"2023","unstructured":"Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V et al (2023) Cannabinoids in neuroinflammatory disorders: focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases. BioFactors. https:\/\/doi.org\/10.1002\/biof.1936","journal-title":"BioFactors"},{"issue":"10","key":"2607_CR2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/hipo.20711","volume":"20","author":"H Abush","year":"2010","unstructured":"Abush H, Akirav I (2010) Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20(10):1126\u20131138","journal-title":"Hippocampus"},{"issue":"3","key":"2607_CR3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neulet.2010.10.067","volume":"487","author":"SK Acheson","year":"2011","unstructured":"Acheson SK, Moore NL, Kuhn CM et al (2011) The synthetic cannabinoid WIN 55212\u20132 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals. Neurosci Lett 487(3):411\u2013414","journal-title":"Neurosci Lett"},{"issue":"2","key":"2607_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13(2):93\u2013110","journal-title":"Cogn Process"},{"issue":"2","key":"2607_CR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-111862","volume":"30","author":"E Aso","year":"2012","unstructured":"Aso E, Palomer E, Juves S et al (2012) CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AbetaPP\/PS1 mice. J Alzheimers Dis 30(2):439\u2013459","journal-title":"J Alzheimers Dis"},{"key":"2607_CR6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2013.09.001","volume":"253","author":"I Balderas","year":"2013","unstructured":"Balderas I, Rodriguez-Ortiz CJ, Bermudez-Rattoni F (2013) Retrieval and reconsolidation of object recognition memory are independent processes in the perirhinal cortex. Neuroscience 253:398\u2013405","journal-title":"Neuroscience"},{"issue":"2","key":"2607_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055821","volume":"8","author":"A Batalla","year":"2013","unstructured":"Batalla A, Bhattacharyya S, Yucel M et al (2013) Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS ONE 8(2):e55821","journal-title":"PLoS ONE"},{"issue":"6","key":"2607_CR8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","volume":"36","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, Queiroz RHC, Chagas MHN et al (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36(6):1219\u20131226","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"2607_CR9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nm.4311","volume":"23","author":"A Bilkei-Gorzo","year":"2017","unstructured":"Bilkei-Gorzo A, Albayram O, Draffehn A et al (2017) A chronic low dose of Delta(9)-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med 23(6):782\u2013787","journal-title":"Nat Med"},{"issue":"4","key":"2607_CR10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00001756-200003200-00019","volume":"11","author":"RI Block","year":"2000","unstructured":"Block RI, O\u2019Leary DS, Hichwa RD et al (2000) Cerebellar hypoactivity in frequent marijuana users. NeuroReport 11(4):749\u2013753","journal-title":"NeuroReport"},{"issue":"1\u20133","key":"2607_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","volume":"463","author":"M Bourin","year":"2003","unstructured":"Bourin M, Hascoet M (2003) The mouse light\/dark box test. Eur J Pharmacol 463(1\u20133):55\u201365","journal-title":"Eur J Pharmacol"},{"key":"2607_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fnagi.2018.00425","volume":"10","author":"C Bouter","year":"2018","unstructured":"Bouter C, Henniges P, Franke TN et al (2018) 18F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer\u2019s disease. Front Aging Neurosci 10:425","journal-title":"Front Aging Neurosci"},{"key":"2607_CR13","volume":"8","author":"C Bouter","year":"2021","unstructured":"Bouter C, Irwin C, Franke TN et al (2021) Quantitative brain positron emission tomography in female 5XFAD Alzheimer mice: pathological features and sex-specific alterations. Front Med (lausanne) 8:745064","journal-title":"Front Med (lausanne)"},{"issue":"3","key":"2607_CR14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08897077.2013.775092","volume":"34","author":"JS Brook","year":"2013","unstructured":"Brook JS, Lee JY, Finch SJ et al (2013) Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abus 34(3):298\u2013305","journal-title":"Subst Abus"},{"issue":"3","key":"2607_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psc.2022.05.002","volume":"45","author":"GM Burnett","year":"2022","unstructured":"Burnett GM, Gorelick DA, Hill KP (2022) Policy ahead of the science: medical cannabis laws versus scientific evidence. Psychiatr Clin North Am 45(3):347\u2013373","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"2607_CR16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1471-4159.2008.05503.x","volume":"106","author":"C Cadoni","year":"2008","unstructured":"Cadoni C, Valentini V, Di Chiara G (2008) Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. J Neurochem 106(4):1586\u20131593","journal-title":"J Neurochem"},{"issue":"8","key":"2607_CR17","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/cns.13848","volume":"28","author":"D Cassar","year":"2022","unstructured":"Cassar D, Radic M, Casarrubea M et al (2022) The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze. CNS Neurosci Ther 28(8):1268\u20131270","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2607_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.pbb.2006.03.006","volume":"83","author":"YM Cha","year":"2006","unstructured":"Cha YM, White AM, Kuhn CM et al (2006) Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav 83(3):448\u2013455","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"2607_CR19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858406296601","volume":"13","author":"L Chang","year":"2007","unstructured":"Chang L, Chronicle EP (2007) Functional imaging studies in cannabis users. Neuroscientist 13(5):422\u2013432","journal-title":"Neuroscientist"},{"key":"2607_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2011.01.024","volume":"178","author":"X Chen","year":"2011","unstructured":"Chen X, Zhang J, Chen C (2011) Endocannabinoid 2-arachidonoylglycerol protects neurons against beta-amyloid insults. Neuroscience 178:159\u2013168","journal-title":"Neuroscience"},{"issue":"7","key":"2607_CR21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00213-017-4546-4","volume":"234","author":"K Cohen","year":"2017","unstructured":"Cohen K, Kapitany-Foveny M, Mama Y et al (2017) The effects of synthetic cannabinoids on executive function. Psychopharmacology 234(7):1121\u20131134","journal-title":"Psychopharmacology"},{"key":"2607_CR22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fpsyt.2020.00602","volume":"11","author":"K Cohen","year":"2020","unstructured":"Cohen K, Mama Y, Rosca P et al (2020) Chronic use of synthetic cannabinoids is associated with impairment in working memory and mental flexibility. Front Psychiatry 11:602","journal-title":"Front Psychiatry"},{"key":"2607_CR23","doi-asserted-by":"crossref","first-page":"153601211770455","DOI":"10.1177\/1536012117704557","volume":"16","author":"RA Coleman","year":"2017","unstructured":"Coleman RA, Liang C, Patel R et al (2017) Brain and brown adipose tissue metabolism in transgenic Tg2576 mice models of alzheimer disease assessed using 18F-FDG PET imaging. Mol Imaging 16:1536012117704557","journal-title":"Mol Imaging"},{"issue":"1","key":"2607_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","volume":"7","author":"JP Connor","year":"2021","unstructured":"Connor JP, Stjepanovic D, Le Foll B et al (2021) Cannabis use and cannabis use disorder. Nat Rev Dis Primers 7(1):16","journal-title":"Nat Rev Dis Primers"},{"key":"2607_CR25","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.20352.1","volume":"8","author":"MB Cooke","year":"2019","unstructured":"Cooke MB, O\u2019Leary TP, Harris P et al (2019) Pathfinder: open source software for analyzing spatial navigation search strategies. F1000Res 8:1521","journal-title":"F1000Res"},{"issue":"11","key":"2607_CR26","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1007\/s12035-020-02054-6","volume":"57","author":"R Cooray","year":"2020","unstructured":"Cooray R, Gupta V, Suphioglu C (2020a) Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson\u2019s and Alzheimer\u2019s diseases: a review. Mol Neurobiol 57(11):4878\u20134890","journal-title":"Mol Neurobiol"},{"key":"2607_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-02054-6","author":"R Cooray","year":"2020","unstructured":"Cooray R, Gupta V, Suphioglu C (2020b) Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson\u2019s and Alzheimer\u2019s diseases: a review. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-020-02054-6","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2607_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41398-021-01295-w","volume":"11","author":"L Cupo","year":"2021","unstructured":"Cupo L, Plitman E, Guma E et al (2021) A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis. Transl Psychiatry 11(1):217","journal-title":"Transl Psychiatry"},{"issue":"1","key":"2607_CR29","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41598-022-09270-1","volume":"12","author":"N Curdt","year":"2022","unstructured":"Curdt N, Schmitt FW, Bouter C et al (2022) Search strategy analysis of Tg4-42 Alzheimer mice in the Morris water maze reveals early spatial navigation deficits. Sci Rep 12(1):5451","journal-title":"Sci Rep"},{"issue":"5","key":"2607_CR30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","volume":"31","author":"E Dere","year":"2007","unstructured":"Dere E, Huston JP, De Souza Silva MA (2007) The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31(5):673\u2013704","journal-title":"Neurosci Biobehav Rev"},{"key":"2607_CR31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta S, Sengupta P (2016) Men and mice: relating their ages. Life Sci 152:244\u2013248","journal-title":"Life Sci"},{"issue":"3","key":"2607_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130050892","volume":"142","author":"H Ehrenreich","year":"1999","unstructured":"Ehrenreich H, Rinn T, Kunert HJ et al (1999) Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 142(3):295\u2013301","journal-title":"Psychopharmacology"},{"issue":"3","key":"2607_CR33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuroimage.2004.07.032","volume":"23","author":"DA Eldreth","year":"2004","unstructured":"Eldreth DA, Matochik JA, Cadet JL et al (2004) Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 23(3):914\u2013920","journal-title":"Neuroimage"},{"issue":"8","key":"2607_CR34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","volume":"151","author":"G Esposito","year":"2007","unstructured":"Esposito G, Scuderi C, Savani C et al (2007) Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol 151(8):1272\u20131279","journal-title":"Br J Pharmacol"},{"key":"2607_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-030-57369-0_5","volume":"1264","author":"D Feingold","year":"2021","unstructured":"Feingold D, Weinstein A (2021) Cannabis and depression. Adv Exp Med Biol 1264:67\u201380","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2607_CR36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s40501-020-00202-2","volume":"7","author":"AS Fischer","year":"2020","unstructured":"Fischer AS, Tapert SF, Lee Louie D et al (2020) Cannabis and the developing adolescent brain. Curr Treat Options Psychiatry 7(2):144\u2013161","journal-title":"Curr Treat Options Psychiatry"},{"key":"2607_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15936","author":"MA Fouda","year":"2022","unstructured":"Fouda MA, Fathy Mohamed Y, Fernandez R et al (2022) Anti-inflammatory effects of cannabidiol against lipopolysaccharides in cardiac sodium channels. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.15936","journal-title":"Br J Pharmacol"},{"key":"2607_CR38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fmed.2020.00529","volume":"7","author":"TN Franke","year":"2020","unstructured":"Franke TN, Irwin C, Bayer TA et al (2020) In vivo imaging with 18F-FDG- and 18F-Florbetaben-PET\/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer\u2019s disease. Front Med (Lausanne) 7:529","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"2607_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055251","volume":"8","author":"S Frisch","year":"2013","unstructured":"Frisch S, Dukart J, Vogt B et al (2013) Dissociating memory networks in early Alzheimer\u2019s disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy. PLoS One 8(2):e55251","journal-title":"PLoS One"},{"key":"2607_CR40","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.122","volume":"2","author":"KA Gleason","year":"2012","unstructured":"Gleason KA, Birnbaum SG, Shukla A et al (2012) Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry 2:e199","journal-title":"Transl Psychiatry"},{"issue":"1","key":"2607_CR41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00406-019-00981-7","volume":"269","author":"C Gorey","year":"2019","unstructured":"Gorey C, Kuhns L, Smaragdi E et al (2019) Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review. Eur Arch Psychiatry Clin Neurosci 269(1):37\u201358","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"5","key":"2607_CR42","first-page":"682","volume":"12","author":"F Haddad","year":"2022","unstructured":"Haddad F, Dokmak G, Karaman R (2022) The efficacy of cannabis on multiple sclerosis-related symptoms. Life (Basel) 12(5):682","journal-title":"Life (Basel)"},{"key":"2607_CR43","volume-title":"Health and social effects of nonmedical cannabis use (the)","author":"W Hall","year":"2016","unstructured":"Hall W, Renstr\u00f6m M, Poznyak V (2016) Health and social effects of nonmedical cannabis use (the). World Health Organization"},{"key":"2607_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102698","volume":"77","author":"D Hammond","year":"2020","unstructured":"Hammond D, Goodman S, Wadsworth E et al (2020) Evaluating the impacts of cannabis legalization: the international cannabis policy study. Int J Drug Policy 77:102698","journal-title":"Int J Drug Policy"},{"issue":"1","key":"2607_CR45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.schres.2015.11.027","volume":"170","author":"S Helle","year":"2016","unstructured":"Helle S, Ringen PA, Melle I et al (2016) Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119). Schizophr Res 170(1):217\u2013221","journal-title":"Schizophr Res"},{"issue":"10","key":"2607_CR46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.31128\/AJGP-04-21-5939","volume":"50","author":"LA Henderson","year":"2021","unstructured":"Henderson LA, Kotsirilos V, Cairns EA et al (2021) Medicinal cannabis in the treatment of chronic pain. Aust J Gen Pract 50(10):724\u2013732","journal-title":"Aust J Gen Pract"},{"issue":"3","key":"2607_CR47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.9758\/cpn.2020.18.3.341","volume":"18","author":"D Himanshu","year":"2020","unstructured":"Himanshu D, Sarkar D et al (2020) A review of behavioral tests to evaluate different types of anxiety and anti-anxiety effects. Clin Psychopharmacol Neurosci 18(3):341\u2013351","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"4","key":"2607_CR48","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2215-0366(20)30074-2","volume":"7","author":"G Hindley","year":"2020","unstructured":"Hindley G, Beck K, Borgan F et al (2020) Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry 7(4):344\u2013353","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"2607_CR49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","volume":"17","author":"J Hirvonen","year":"2012","unstructured":"Hirvonen J, Goodwin RS, Li CT et al (2012) Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17(6):642\u2013649","journal-title":"Mol Psychiatry"},{"issue":"16","key":"2607_CR50","first-page":"271","volume":"112","author":"E Hoch","year":"2015","unstructured":"Hoch E, Bonnet U, Thomasius R et al (2015) Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int 112(16):271\u2013278","journal-title":"Dtsch Arztebl Int"},{"issue":"Pt 6","key":"2607_CR51","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","volume":"126","author":"L Iversen","year":"2003","unstructured":"Iversen L (2003) Cannabis and the brain. Brain 126(Pt 6):1252\u20131270","journal-title":"Brain"},{"issue":"13","key":"2607_CR52","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2174\/13816128113199990426","volume":"20","author":"J Jacobus","year":"2014","unstructured":"Jacobus J, Tapert SF (2014) Effects of cannabis on the adolescent brain. Curr Pharm Des 20(13):2186\u20132193","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2607_CR53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-013-9984-x","volume":"34","author":"E Janefjord","year":"2014","unstructured":"Janefjord E, Maag JL, Harvey BS et al (2014) Cannabinoid effects on beta amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro. Cell Mol Neurobiol 34(1):31\u201342","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"2607_CR54","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","volume":"115","author":"W Jiang","year":"2005","unstructured":"Jiang W, Zhang Y, Xiao L et al (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115(11):3104\u20133116","journal-title":"J Clin Invest"},{"issue":"2","key":"2607_CR55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.66.2.204","volume":"66","author":"K Jin","year":"2004","unstructured":"Jin K, Xie L, Kim SH et al (2004) Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 66(2):204\u2013208","journal-title":"Mol Pharmacol"},{"key":"2607_CR56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2017.10.012","volume":"163","author":"CR Kasten","year":"2017","unstructured":"Kasten CR, Zhang Y, Boehm SL 2nd (2017) Acute and long-term effects of Delta9-tetrahydrocannabinol on object recognition and anxiety-like activity are age- and strain-dependent in mice. Pharmacol Biochem Behav 163:9\u201319","journal-title":"Pharmacol Biochem Behav"},{"key":"2607_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-022-00438-3.1-17","author":"JH Khalsa","year":"2022","unstructured":"Khalsa JH, Bunt G, Blum K et al (2022) Review: cannabinoids as medicinals. Curr Addict Rep. https:\/\/doi.org\/10.1007\/s40429-022-00438-3.1-17","journal-title":"Curr Addict Rep"},{"issue":"23","key":"2607_CR58","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/ijms20235905","volume":"20","author":"B Kis","year":"2019","unstructured":"Kis B, Ifrim FC, Buda V et al (2019) Cannabidiol-from plant to human body: a promising bioactive molecule with multi-target effects in cancer. Int J Mol Sci 20(23):5905","journal-title":"Int J Mol Sci"},{"key":"2607_CR59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8994-2_4","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z (2019) The elevated plus maze test for measuring anxiety-like behavior in rodents. Methods Mol Biol 1916:69\u201374","journal-title":"Methods Mol Biol"},{"key":"2607_CR60","doi-asserted-by":"crossref","first-page":"154485","DOI":"10.1016\/j.phymed.2022.154485","volume":"107","author":"JS Laws 3rd","year":"2022","unstructured":"Laws JS 3rd, Smid SD (2022) Evaluating Cannabis sativa L.\u2019s neuroprotection potential: from bench to bedside. Phytomedicine 107:154485","journal-title":"Phytomedicine"},{"issue":"9","key":"2607_CR61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.euroneuro.2018.07.095","volume":"28","author":"A Livny","year":"2018","unstructured":"Livny A, Cohen K, Tik N et al (2018) The effects of synthetic cannabinoids (SCs) on brain structure and function. Eur Neuropsychopharmacol 28(9):1047\u20131057","journal-title":"Eur Neuropsychopharmacol"},{"issue":"17","key":"2607_CR62","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.3390\/ijms22179472","volume":"22","author":"H Lowe","year":"2021","unstructured":"Lowe H, Toyang N, Steele B et al (2021) The endocannabinoid system: a potential target for the treatment of various diseases. Int J Mol Sci 22(17):9472","journal-title":"Int J Mol Sci"},{"key":"2607_CR63","doi-asserted-by":"publisher","DOI":"10.3791\/55718.(126)","author":"LM Lueptow","year":"2017","unstructured":"Lueptow LM (2017) Novel object recognition test for the investigation of learning and memory in mice. J vis Exp. https:\/\/doi.org\/10.3791\/55718.(126)","journal-title":"J vis Exp"},{"issue":"5","key":"2607_CR64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0892-0362(01)00165-9","volume":"23","author":"T Lundqvist","year":"2001","unstructured":"Lundqvist T, Jonsson S, Warkentin S (2001) Frontal lobe dysfunction in long-term cannabis users. Neurotoxicol Teratol 23(5):437\u2013443","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"2607_CR65","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/1567205011666140505111354","volume":"11","author":"IR Macdonald","year":"2014","unstructured":"Macdonald IR, DeBay DR, Reid GA et al (2014) Early detection of cerebral glucose uptake changes in the 5XFAD mouse. Curr Alzheimer Res 11(5):450\u2013460","journal-title":"Curr Alzheimer Res"},{"key":"2607_CR66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","volume":"9","author":"AM Martin-Moreno","year":"2012","unstructured":"Martin-Moreno AM, Brera B, Spuch C et al (2012) Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation 9:8","journal-title":"J Neuroinflammation"},{"issue":"14","key":"2607_CR67","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.3390\/ijms23147891","volume":"23","author":"JJ McDougall","year":"2022","unstructured":"McDougall JJ, McKenna MK (2022) Anti-inflammatory and analgesic properties of the cannabis terpene myrcene in rat adjuvant monoarthritis. Int J Mol Sci 23(14):7891","journal-title":"Int J Mol Sci"},{"key":"2607_CR68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000356430","volume":"34","author":"K Moodley","year":"2014","unstructured":"Moodley K, Chan D (2014) The hippocampus in neurodegenerative disease. Hippocampus Clin Neurosci 34:95\u2013108","journal-title":"Hippocampus Clin Neurosci"},{"issue":"1","key":"2607_CR69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jnc.14549","volume":"147","author":"FM Mouro","year":"2018","unstructured":"Mouro FM, Ribeiro JA, Sebastiao AM et al (2018) Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity. J Neurochem 147(1):71\u201383","journal-title":"J Neurochem"},{"issue":"7","key":"2607_CR70","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","volume":"1","author":"P Nagarkatti","year":"2009","unstructured":"Nagarkatti P, Pandey R, Rieder SA et al (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1(7):1333\u20131349","journal-title":"Future Med Chem"},{"key":"2607_CR71","unstructured":"Nations U (2018) World drug report 2018 (set of 5 booklets). UN"},{"issue":"3","key":"2607_CR72","first-page":"1002","volume":"253","author":"ES Onaivi","year":"1990","unstructured":"Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253(3):1002\u20131009","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2607_CR73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/026988110401800407","volume":"18","author":"M O'Shea","year":"2004","unstructured":"O\u2019Shea M, Singh ME, McGregor IS et al (2004) Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol 18(4):502\u2013508","journal-title":"J Psychopharmacol"},{"issue":"11","key":"2607_CR74","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/npp.2010.100","volume":"35","author":"CM O'Tuathaigh","year":"2010","unstructured":"O\u2019Tuathaigh CM, Hryniewiecka M, Behan A et al (2010) Chronic adolescent exposure to Delta-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology 35(11):2262\u20132273","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"2607_CR75","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3390\/ijms23063344","volume":"23","author":"C Pagano","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L et al (2022) Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci 23(6):3344","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2607_CR76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0019-5545.75552","volume":"53","author":"SR Parkar","year":"2011","unstructured":"Parkar SR, Ramanathan S, Nair N et al (2011) Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. Indian J Psychiatry 53(1):13\u201320","journal-title":"Indian J Psychiatry"},{"issue":"7","key":"2607_CR77","first-page":"e9309","volume":"12","author":"S Patel","year":"2020","unstructured":"Patel S, Khan S, Saipavankumar M et al (2020) The association between cannabis use and schizophrenia: causative or curative? A systematic review. Cureus 12(7):e9309","journal-title":"Cureus"},{"issue":"6","key":"2607_CR78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FBP.0000000000000323","volume":"28","author":"N Pintori","year":"2017","unstructured":"Pintori N, Loi B, Mereu M (2017) Synthetic cannabinoids: the hidden side of spice drugs. Behav Pharmacol 28(6):409\u2013419","journal-title":"Behav Pharmacol"},{"issue":"6","key":"2607_CR79","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0893-133X(99)00064-0","volume":"21","author":"FE Pontieri","year":"1999","unstructured":"Pontieri FE, Conti G, Zocchi A et al (1999) Metabolic mapping of the effects of WIN 55212\u20132 intravenous administration in the rat. Neuropsychopharmacology 21(6):773\u2013776","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2607_CR80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00131746-200505000-00004","volume":"11","author":"B Raphael","year":"2005","unstructured":"Raphael B, Wooding S, Stevens G et al (2005) Comorbidity: cannabis and complexity. J Psychiatr Pract 11(3):161\u2013176","journal-title":"J Psychiatr Pract"},{"key":"2607_CR81","volume":"359","author":"DS Reddy","year":"2022","unstructured":"Reddy DS (2022) Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies. Exp Neurol 359:114237","journal-title":"Exp Neurol"},{"issue":"2","key":"2607_CR82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0253-7176.63575","volume":"31","author":"C Rodrigo","year":"2009","unstructured":"Rodrigo C, Rajapakse S (2009) Cannabis and schizophrenia spectrum disorders: a review of clinical studies. Indian J Psychol Med 31(2):62\u201370","journal-title":"Indian J Psychol Med"},{"issue":"6","key":"2607_CR83","first-page":"417","volume":"24","author":"S Rubinstein Levy","year":"2022","unstructured":"Rubinstein Levy S, Halpert G, Amita H (2022) Cannabis and autoimmune diseases. Isr Med Assoc J 24(6):417\u2013420","journal-title":"Isr Med Assoc J"},{"issue":"16","key":"2607_CR84","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1046\/j.1432-1327.2000.01550.x","volume":"267","author":"M Salzet","year":"2000","unstructured":"Salzet M, Breton C, Bisogno T et al (2000) Comparative biology of the endocannabinoid system possible role in the immune response. Eur J Biochem 267(16):4917\u20134927","journal-title":"Eur J Biochem"},{"issue":"19","key":"2607_CR85","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.3390\/ijms231911159","volume":"23","author":"EM Schleicher","year":"2022","unstructured":"Schleicher EM, Bayer TA, Iseni T et al (2022) Ablation of the presynaptic protein mover impairs learning performance and decreases anxiety behavior in mice. Int J Mol Sci 23(19):11159","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2607_CR86","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JAD-180230","volume":"64","author":"AC Schmole","year":"2018","unstructured":"Schmole AC, Lundt R, Toporowski G et al (2018) Cannabinoid receptor 2-deficiency ameliorates disease symptoms in a mouse model with Alzheimer\u2019s disease-like pathology. J Alzheimers Dis 64(2):379\u2013392","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"2607_CR87","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1300225","volume":"28","author":"M Schneider","year":"2003","unstructured":"Schneider M, Koch M (2003) Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28(10):1760\u20131769","journal-title":"Neuropsychopharmacology"},{"issue":"3\u20134","key":"2607_CR88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1369-1600.2008.00117.x","volume":"13","author":"M Schneider","year":"2008","unstructured":"Schneider M, Schomig E, Leweke FM (2008) Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict Biol 13(3\u20134):345\u2013357","journal-title":"Addict Biol"},{"issue":"4","key":"2607_CR89","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00213-006-0676-9","volume":"191","author":"NL Schramm-Sapyta","year":"2007","unstructured":"Schramm-Sapyta NL, Cha YM, Chaudhry S et al (2007) Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology 191(4):867\u2013877","journal-title":"Psychopharmacology"},{"issue":"4","key":"2607_CR90","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1075-1","volume":"197","author":"S Sevy","year":"2008","unstructured":"Sevy S, Smith GS, Ma Y et al (2008) Cerebral glucose metabolism and D2\/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology 197(4):549\u2013556","journal-title":"Psychopharmacology"},{"issue":"2","key":"2607_CR91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/glia.20108","volume":"49","author":"WS Sheng","year":"2005","unstructured":"Sheng WS, Hu S, Min X et al (2005) Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia 49(2):211\u2013219","journal-title":"Glia"},{"issue":"3","key":"2607_CR92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0019-5545.86796","volume":"53","author":"A Shrivastava","year":"2011","unstructured":"Shrivastava A, Johnston M, Tsuang M (2011) Cannabis use and cognitive dysfunction. Indian J Psychiatry 53(3):187\u2013191","journal-title":"Indian J Psychiatry"},{"issue":"6","key":"2607_CR93","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/adb.12446","volume":"22","author":"J Tomas-Roig","year":"2017","unstructured":"Tomas-Roig J, Benito E, Agis-Balboa RC et al (2017) Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice. Addict Biol 22(6):1778\u20131789","journal-title":"Addict Biol"},{"issue":"3","key":"2607_CR94","doi-asserted-by":"crossref","first-page":"286","DOI":"10.21307\/ane-2020-025","volume":"80","author":"M Velikova","year":"2020","unstructured":"Velikova M, Doncheva D, Tashev R (2020) Subchronic effects of ligands of cannabinoid receptors on learning and memory processes of olfactory bulbectomized rats. Acta Neurobiol Exp (Wars) 80(3):286\u2013296","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"23","key":"2607_CR95","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM et al (2014) Adverse health effects of marijuana use. N Engl J Med 370(23):2219\u20132227","journal-title":"N Engl J Med"},{"key":"2607_CR96","volume":"242","author":"S Wang","year":"2020","unstructured":"Wang S, Lai X, Deng Y et al (2020) Correlation between mouse age and human age in anti-tumor research: significance and method establishment. Life Sci 242:117242","journal-title":"Life Sci"},{"issue":"8","key":"2607_CR97","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.neuropsychologia.2009.12.022","volume":"48","author":"EC Warburton","year":"2010","unstructured":"Warburton EC, Brown MW (2010) Findings from animals concerning when interactions between perirhinal cortex, hippocampus and medial prefrontal cortex are necessary for recognition memory. Neuropsychologia 48(8):2262\u20132272","journal-title":"Neuropsychologia"},{"key":"2607_CR98","volume":"12","author":"T Wenger","year":"2021","unstructured":"Wenger T, Watanabe K, Sasaki Y et al (2021) Overview of cannabis including kampo medicine and therapy for treatment of dementia: a review. Front Pharmacol 12:713228","journal-title":"Front Pharmacol"},{"issue":"5568","key":"2607_CR99","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296(5568):678\u2013682","journal-title":"Science"},{"issue":"1\u20132","key":"2607_CR100","first-page":"31","volume":"16","author":"RR Yeruva","year":"2019","unstructured":"Yeruva RR, Mekala HM, Sidhu M et al (2019) Synthetic cannabinoids-\"spice\" can induce a psychosis: a brief review. Innov Clin Neurosci 16(1\u20132):31\u201332","journal-title":"Innov Clin Neurosci"},{"issue":"6","key":"2607_CR101","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpsyc.65.6.694","volume":"65","author":"M Yucel","year":"2008","unstructured":"Yucel M, Solowij N, Respondek C et al (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 65(6):694\u2013701","journal-title":"Arch Gen Psychiatry"},{"key":"2607_CR102","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.201","volume":"6","author":"M Yucel","year":"2016","unstructured":"Yucel M, Lorenzetti V, Suo C et al (2016) Hippocampal harms, protection and recovery following regular cannabis use. Transl Psychiatry 6:e710","journal-title":"Transl Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-023-02607-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02607-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T16:22:26Z","timestamp":1690474946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-023-02607-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":102,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2607"],"URL":"https:\/\/doi.org\/10.1007\/s00702-023-02607-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animals were handled according to the German guidelines and EU legislation for animal care and the experiments were approved by the local authorities (Nieders\u00e4chsisches Landesamt f\u00fcr Verbraucherschutz [16\/2364, 17\/2614] and Landesamt f\u00fcr Gesundheit und Soziales LAGeSo Darwinstr. 15, 10589 Berlin [65\/18, 260\/19]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}